This is a routine administrative filing with no trading implications. Monitor for future 6-K filings that may contain material business or financial updates.
Price Chart
Executive Summary
Helus Pharma Inc. filed a Form 6-K with Exhibit 99.1, which is a Certificate and Articles of Amendment. The filing is a routine corporate governance document with no financial data, business updates, or material events disclosed. The document content was largely unreadable binary data, but the metadata confirms it is a non-financial administrative filing.
Key Facts
- Filed Form 6-K on October 5, 2026, with a period of report of October 1, 2026
- Exhibit 99.1 is a Certificate and Articles of Amendment
- No financial figures, business updates, or material events disclosed
- Document content was largely unreadable binary data (graphic files)
Financial Impact
No financial impact — filing is a routine corporate amendment with no disclosed financial data
Risk Factors
- No material risks identified from this filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001062993-26-005176 |
| Document: 0001062993-26-005176-index-headers.html | 0001062993-26-005176 |
| Document: 0001062993-26-005176-index.html | 0001062993-26-005176 |
| Document: 0001062993-26-005176.txt | 0001062993-26-005176 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $10.66 | awaiting T+20 | — | $10.36 (−2.77%) |
Oct 26, 2026 1d ago | 3 | $10.36 | awaiting T+20 | — | $10.36 (−0.00%) |
Oct 26, 2026 1d ago | 3 | $10.36 | awaiting T+20 | — | $10.36 (−0.00%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | — | $10.36 (−0.00%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | — | $10.36 (−0.00%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | — | $10.36 (−0.00%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | — | $10.36 (−0.00%) |
Oct 21, 2026 6d ago | 6-K | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 15, 2026 12d ago | 6-K | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 15, 2026 12d ago | Press Release | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers